On ECHEMI
Home > Drugs > Jilin Connell Pharmaceutical Co., Ltd.
Jilin Connell Pharmaceutical Co., Ltd.
  • Founded in:

    2001-11-28
  • Country:

    China China
  • Address:

    No. 198, Chuangxin 3rd Road, High-tech Zone, Jilin City
  • Tax NO.:

    91220214732553110Y
  • Registered Funds:

    62.54717 million yuan
  • Website:

  • Email:

Related Drugs
Compound Monoammonium Glycyrrhizinate S Sodium Chloride Injection
This product is a compound preparation, whose components are: monoammonium glycyrrhizinate S (C42H65NO16·2H20), glycine (C2H5NO2), cysteine hydrochloride (C3H7NO2S·HCl·H2O), and sodium chloride (NaCl).
Name Description Content CAS NO. Registered Holders
Monoammonium glycyrrhizinate S

It has a strong affinity for liver cholesterol metabolic enzymes, thereby hindering the inactivation of cortisol and aldosterone, showing obvious corticosteroid-like effects (such as anti-inflammatory, anti-allergic and protective membrane structure, etc.) without obvious corticosteroid-like side effects; it promotes bile pigment metabolism and reduces the release of ALT and AST; it induces γ-IFN and interleukin II, increases NK cell activity and the OKT4/OKT8 ratio and activates the reticuloendothelial system; it inhibits the release of histamine from mast cells; it inhibits the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reactions; it inhibits the production and formation of free radicals and lipid peroxides, and reduces the activity of prolyl hydroxylase; it regulates calcium ion channels and protects lysosomal membranes and mitochondria.

More

It has a strong affinity for liver cholesterol metabolic enzymes, thereby hindering the inactivation of cortisol and aldosterone, showing obvious corticosteroid-like effects (such as anti-inflammatory, anti-allergic and protective membrane structure, etc.) without obvious corticosteroid-like side effects; it promotes bile pigment metabolism and reduces the release of ALT and AST; it induces γ-IFN and interleukin II, increases NK cell activity and the OKT4/OKT8 ratio and activates the reticuloendothelial system; it inhibits the release of histamine from mast cells; it inhibits the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reactions; it inhibits the production and formation of free radicals and lipid peroxides, and reduces the activity of prolyl hydroxylase; it regulates calcium ion channels and protects lysosomal membranes and mitochondria.

0
Glycine

Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell

More

Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell

56-40-6 27
L-Cysteine monohydrochloride

Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell

More

Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell

52-89-1 10
Sodium chloride

Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell

More

Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell

7647-14-5 43
Dextran 20 Glucose Injection
Main ingredients: This product is a sterile aqueous solution of dextran 20 and glucose. Dextran 20 is a small molecule glucose polymer generated by fermentation of sucrose, with an average molecular weight of 20,000.
Name Description Content CAS NO. Registered Holders
Dextran 20

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

0
GLUCOSE

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

58367-01-4 14
Dextran 20 Glucose Injection
Main ingredients: This product is a sterile aqueous solution of dextran 20 and glucose. Dextran 20 is a small molecule glucose polymer generated by fermentation of sucrose, with an average molecular weight of 20,000.
Name Description Content CAS NO. Registered Holders
Dextran 20

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity.

0
GLUCOSE

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

58367-01-4 14
Dextran 20 Glucose Injection
Main ingredients: This product is a sterile aqueous solution of dextran 20 and glucose. Dextran 20 is a small molecule glucose polymer generated by fermentation of sucrose, with an average molecular weight of 20,000.
Name Description Content CAS NO. Registered Holders
Dextran 20

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

0
GLUCOSE

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

58367-01-4 14
Ligustrazine Hydrochloride Sodium Chloride Injection
This product is a compound preparation, its components are: 100ml: 0.04g of ligustrazine hydrochloride and 0.9g of sodium chloride
Name Description Content CAS NO. Registered Holders
Ligustrazine Hydrochloride

It can expand the coronary artery, reduce blood pressure, improve myocardial hypoxia tolerance, inhibit platelet aggregation, excite the respiratory center, relax bronchial smooth muscle, improve high ventilation function, prevent the formation of immune complexes, inhibit the growth of pathogens, promote inflammation absorption, enhance capillary density, reduce blood viscosity, improve blood circulation, and increase the supply of visceral organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects.

More

It can expand the coronary artery, reduce blood pressure, improve myocardial hypoxia tolerance, inhibit platelet aggregation, excite the respiratory center, relax bronchial smooth muscle, improve high ventilation function, prevent the formation of immune complexes, inhibit the growth of pathogens, promote inflammation absorption, enhance capillary density, reduce blood viscosity, improve blood circulation, and increase the supply of visceral organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects.

0.04g 76494-51-4 12
Sodium chloride

Ligustrazine is an alkaloid extracted from the traditional Chinese medicine Ligustrazine, and its chemical structure is tetra-pyrazine. Modern pharmacological studies have shown that Ligustrazine has the effects of expanding the coronary artery, lowering blood pressure, improving myocardial hypoxia tolerance, inhibiting platelet aggregation, exciting the respiratory center, relaxing bronchial smooth muscle, improving high ventilation function, preventing the formation of immune complexes, inhibiting the growth of pathogens, promoting inflammatory absorption, enhancing capillary density, reducing blood viscosity, improving blood circulation, and increasing the supply of visceral important organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects.

More

Ligustrazine is an alkaloid extracted from the traditional Chinese medicine Ligustrazine, and its chemical structure is tetra-pyrazine. Modern pharmacological studies have shown that Ligustrazine has the effects of expanding the coronary artery, lowering blood pressure, improving myocardial hypoxia tolerance, inhibiting platelet aggregation, exciting the respiratory center, relaxing bronchial smooth muscle, improving high ventilation function, preventing the formation of immune complexes, inhibiting the growth of pathogens, promoting inflammatory absorption, enhancing capillary density, reducing blood viscosity, improving blood circulation, and increasing the supply of visceral important organs. This product has anti-platelet aggregation and has a depolymerization effect on aggregated and platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thereby producing anti-thrombotic and thrombolytic effects.

0.9g 7647-14-5 43
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.